On September 11,2025, the fourth session of the Autoimmune Diseases Symposium Series in Rheumatology and Immunology, organized by the Chengdu High-Tech Medical Association, was successfully concluded.
The event brought together leading experts and scholars from China's rheumatology and immunology fields to discuss the latest research advancements and clinical strategies for autoimmune diseases.
While medical technology has made significant progress in diagnosing and treating these conditions, numerous challenges remain to be addressed.
This academic symposium aimed to create a high-level platform for experts in the field to share research achievements and clinical experiences.
During the keynote presentations, multiple experts delivered insightful speeches.
Professor Su Jiang from Sichuan Provincial People's Hospital presented "EULAR 2025 Systemic Lupus Erythematosus Academic Frontiers", systematically introducing the latest advancements in cutting-edge treatment protocols and future research directions.
Professor Lin Fu' an focused on "Clinical Exploration of First-line Biological Therapy for Systemic Lupus Erythematosus", proposing innovative personalized treatment strategies through analysis of recent clinical studies.
The panel discussion session was lively, with experts engaging in in-depth discussions on topics like "Optimizing Biological Therapy Applications in Rheumatologic and Immune Diseases".
The dynamic exchange of ideas sparked continuous academic innovation through intellectual debates and fresh perspectives.
The conference featured a dedicated case discussion session where participants analyzed diagnostic approaches and explored treatment strategies through sharing clinical cases, including both typical and complex cases, significantly enhancing practical clinical skills.
Covering multidimensional aspects from basic research to clinical diagnosis and drug development, the symposium demonstrated China's cutting-edge research capabilities and clinical expertise in rheumatology and immunology.
The ongoing series of academic conferences will profoundly impact regional development in rheumatology and immunology, driving improvements in diagnostic and therapeutic standards.
By continuing to focus on frontier topics in the field, the conference aims to contribute to advancing autoimmune disease prevention and treatment in China.
